JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB54037

Anti-DGAT1 antibody

Be the first to review this product! Submit a review

|

(25 Publications)

Rabbit Polyclonal DGAT1 antibody. Suitable for WB and reacts with Human samples. Cited in 25 publications. Immunogen corresponding to Synthetic Peptide within Human DGAT1.

View Alternative Names

AGRP1, DGAT, DGAT1, Diacylglycerol O-acyltransferase 1, ACAT-related gene product 1, Acyl-CoA retinol O-fatty-acyltransferase, Diglyceride acyltransferase, ARAT, Retinol O-fatty-acyltransferase

2 Images
Western blot - Anti-DGAT1 antibody (AB54037)
  • WB

Unknown

Western blot - Anti-DGAT1 antibody (AB54037)

All lanes:

Western blot - Anti-DGAT1 antibody (ab54037) at 2 µg/mL

All lanes:

HepG2 lysate

Predicted band size: 55 kDa

Observed band size: 55 kDa

false

Western blot - Anti-DGAT1 antibody (AB54037)
  • WB

CiteAb

Western blot - Anti-DGAT1 antibody (AB54037)

Western Blotting using Anti-DGAT1 antibody, ab54037. Publication image from Corbet, C. et al., 2020, Nat Commun, 31974393. Legend direct from paper.

TGF-β2 promotes FA uptake and TG accumulation into LD.a–c Abundance of neutral lipids (NL), phospholipids (PL) and free fatty acids (FFA) (a), abundance of saturated and monounsaturated fatty acids (SFA and MUFA, respectively) in the neutral lipid fraction (b), and LD content (c) in native SiHa cells after treatment with 4 ng/ml TGF-β2 for 6 h. d, e14C-palmitate uptake for 10 min in SiHa cells after treatment with 4 ng/ml TGF-β2 for 6 h (d) and in acidosis-adapted SiHa cells following treatment with 10 µM Trabedersen for 7 days in absence or presence of 4 ng/ml TGF-β2 for 24 h (e). f–h Representative immunoblotting for cell surface-localized CD36 and total biotinylated proteins in native and acidosis-adapted SiHa cells following treatment with 4 ng/ml TGF-β2 for 6 h and 24 h (f), following treatment with 10 µM Trabedersen for 7 days or 2 µM SB431542 for 24 h (g) or with 4 ng/ml TGF-β2 and 10 µM PKC-ζ pseudo-substrate inhibitor for 24 h (h). i, j Quantification of surface-localized CD36 in native and acidosis-adapted SiHa cells treated as indicated in (h). k, l mRNA (k) and protein expression of DGAT1 (l) in native and acidosis-adapted tumor cells. m–o Representative immunoblotting for DGAT1 in native and acidosis-adapted SiHa cells following treatment with 10 µM Trabedersen for 7 days or 2 µM SB431542 for 24 h (m), with 10 µM PKC-ζ pseudo-substrate inhibitor for 24 h (n) or with 10 µM GW6471 for 48 h (o). p mRNA expression of PLIN2 in native and acidosis-adapted SiHa cells following treatment with 10 µM TGFβ2-specific antisense oligonucleotide Trabedersen for 7 days. q Co-expression analysis of TGFB2, PLIN1, PLIN2, and PLIN3 genes in human healthy volunteers and colorectal cancer patient samples. Data are represented as mean ± SEM of three independent experiments (with ≥6 technical replicates). Significance was determined by Student’s t-test (c, d, j), by one-way ANOVA (e–i) or two-way ANOVA (a, k, p) with Bonferroni multiple-comparison analysis. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. Source data are provided as a Source Data file.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human DGAT1. The exact immunogen used to generate this antibody is proprietary information.

O75907

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Zebrafish": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.05% Sodium azide Constituents: Tris glycine, 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DGAT1 also known as acyl CoA:diacylglycerol acyltransferase 1 is an enzyme with a molecular mass of approximately 55 kDa. DGAT1 is expressed in various tissues with high levels noted in adipose tissue and the intestines. The enzyme catalyzes the final step in triglyceride synthesis by transferring acyl-CoA to diacylglycerol to form triglycerides. This process is essential in lipid metabolism impacting both energy storage and membrane synthesis.
Biological function summary

DGAT1 plays a significant role in lipid homeostasis and energy balance across multiple biological systems. This enzyme is key in the conversion of dietary fats into stored energy and it does not exist as part of a complex. DGAT1's activity contributes to the maintenance of cellular lipid droplets and it has implications therefore in conditions where lipid metabolism is disrupted.

Pathways

DGAT1 is a part of the triglyceride biosynthesis pathway an important route within the lipid metabolism framework. In this context the enzyme works alongside other lipogenic proteins such as acetyl-CoA carboxylase and fatty acid synthase to synthesize triglycerides. DGAT1's role in this pathway has implications for how the body manages fat storage and utilization linking it to the regulation of systemic energy levels.

Aberrant DGAT1 activity links to metabolic conditions such as obesity and type 2 diabetes. Alterations in DGAT1 expression can affect lipid storage and mobilization contributing to these disorders. Within this pathogenic context DGAT1 also interacts with proteins like adipose triglyceride lipase which further influences the breakdown of stored triglycerides impacting adipose tissue accumulation and insulin sensitivity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates (PubMed : 16214399, PubMed : 18768481, PubMed : 28420705, PubMed : 32433610, PubMed : 32433611, PubMed : 9756920). Highly expressed in epithelial cells of the small intestine and its activity is essential for the absorption of dietary fats (PubMed : 18768481). In liver, plays a role in esterifying exogenous fatty acids to glycerol, and is required to synthesize fat for storage (PubMed : 16214399). Also present in female mammary glands, where it produces fat in the milk (By similarity). May be involved in VLDL (very low density lipoprotein) assembly (PubMed : 18768481). In contrast to DGAT2 it is not essential for survival (By similarity). Functions as the major acyl-CoA retinol acyltransferase (ARAT) in the skin, where it acts to maintain retinoid homeostasis and prevent retinoid toxicity leading to skin and hair disorders (PubMed : 16214399). Exhibits additional acyltransferase activities, includin acyl CoA : monoacylglycerol acyltransferase (MGAT), wax monoester and wax diester synthases (By similarity). Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) (PubMed : 28420705).
See full target information DGAT1

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

Journal of cardiovascular translational research : PubMed39384702

2024

Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities.

Applications

Unspecified application

Species

Unspecified reactive species

Ke Zhen,Xiaojuan Wei,Zelun Zhi,Shiyu Shang,Shuyan Zhang,Yilu Xu,Xiaochuan Fu,Linjia Cheng,Jing Yao,Yue Li,Xia Chen,Pingsheng Liu,Hongchao Zhang

Journal of animal science and biotechnology 15:105 PubMed39098913

2024

CAMKK2-AMPK axis endows dietary calcium and phosphorus levels with regulatory effects on lipid metabolism in weaned piglets.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyan Miao,Yanjie Sun,Zhangjian Feng,Qiwen Wu,Xuefen Yang,Li Wang,Zongyong Jiang,Ying Li,Hongbo Yi

Physiological reports 11:e15608 PubMed36802195

2023

Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts.

Applications

Unspecified application

Species

Unspecified reactive species

Toshifumi Ogawa,Hidemichi Kouzu,Arata Osanami,Yuki Tatekoshi,Tatsuya Sato,Atsushi Kuno,Yugo Fujita,Shoya Ino,Masaki Shimizu,Yuki Toda,Wataru Ohwada,Toshiyuki Yano,Masaya Tanno,Takayuki Miki,Tetsuji Miura

Cell reports 39:110995 PubMed35732120

2022

Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel J Wilcock,Andrew P Badrock,Chun W Wong,Rhys Owen,Melissa Guerin,Andrew D Southam,Hannah Johnston,Brian A Telfer,Paul Fullwood,Joanne Watson,Harriet Ferguson,Jennifer Ferguson,Gavin R Lloyd,Andris Jankevics,Warwick B Dunn,Claudia Wellbrock,Paul Lorigan,Craig Ceol,Chiara Francavilla,Michael P Smith,Adam F L Hurlstone

Cell metabolism 33:1701-1715.e5 PubMed34118189

2021

Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects.

Applications

Unspecified application

Species

Unspecified reactive species

Emeline Dierge,Elena Debock,Céline Guilbaud,Cyril Corbet,Eric Mignolet,Louise Mignard,Estelle Bastien,Chantal Dessy,Yvan Larondelle,Olivier Feron

Cell death & disease 11:914 PubMed33099578

2020

High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Sun,Xin Ge,Xue Li,Jinrong He,Xinzhi Wei,Jie Du,Jian Sun,Xin Li,Zhe Xun,Weicheng Liu,Hao Zhang,Zhan-You Wang,Yan Chun Li

Cells 9: PubMed32977490

2020

The Absence of NLRP3-inflammasome Modulates Hepatic Fibrosis Progression, Lipid Metabolism, and Inflammation in KO NLRP3 Mice during Aging.

Applications

Unspecified application

Species

Unspecified reactive species

Paloma Gallego,Beatriz Castejón-Vega,José A Del Campo,Mario D Cordero

The Journal of nutritional biochemistry 80:108364 PubMed32199344

2020

Creb-Pgc1α pathway modulates the interaction between lipid droplets and mitochondria and influences high fat diet-induced changes of lipid metabolism in the liver and isolated hepatocytes of yellow catfish.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Feng Song,Christer Hogstrand,Shi-Cheng Ling,Guang-Hui Chen,Zhi Luo

Nature communications 11:454 PubMed31974393

2020

TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Cyril Corbet,Estelle Bastien,Joao Pedro Santiago de Jesus,Emeline Dierge,Ruben Martherus,Catherine Vander Linden,Bastien Doix,Charline Degavre,Céline Guilbaud,Laurenne Petit,Carine Michiels,Chantal Dessy,Yvan Larondelle,Olivier Feron

Diabetes & metabolism journal 43:683-699 PubMed31694081

2019

PF-04620110, a Potent Antidiabetic Agent, Suppresses Fatty Acid-Induced NLRP3 Inflammasome Activation in Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Seung Il Jo,Jung Hwan Bae,Seong Jin Kim,Jong Min Lee,Ji Hun Jeong,Jong Seok Moon
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com